ATAI
is active in a broad range of clinical cognition models enhances cognition in mouse rat and dog species reverses scopolamine induced memory deficit in both tox species consistent inverted shaped relationship across species pro cognitive effects translate to humans was pharmacologically defined using electrophysiology also | ATAI
Company
Deck date
June 2020
Slide
43 of 49
Similar slides by ATAI
Investor Day
January 2022
Other recent decks by ATAI
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2024 Slidebook.io